Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 2151

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 11
Chunk 2151
---
).

    10.11+
     
    Employment
    Agreement (Eric Lang) (filed as Exhibit 10.7 to Registrant’s Registration Statement on Form S-1/A, filed with the SEC
    on June 30, 2023 and incorporated by reference herein).

    10.12+
     
    First
    Amendment to Channel Therapeutics Corporation 2023 Equity Incentive Plan (filed as Exhibit 4.4 to Registrant’s Registration
    Statement on Form S-8, filed with the SEC on April 15, 2024 and incorporated by reference herein).

    10.13
     
    Side
    Letter re Securities Purchase Agreement (Standby Shares) (filed as Exhibit 10.13 to Registrant’s Registration Statement
    on Form S-1/A, filed with the SEC on January 16, 2024 and incorporated by reference herein).

    10.14+
     
    Benuvia
    License Agreement (filed as Exhibit 10.14 to Registrant’s Registration Statement on Form S-1/A, filed with the SEC on
    January 16, 2024 and incorporated by reference herein).

    10.15
     
    Consulting
    Agreement (Francis Knuettel II) (filed as Exhibit 10.3 to Registrant’s Registration Statement on Form S-1/A, filed with
    the SEC on January 20, 2023 and incorporated by reference herein).

    10.16
     
    Form
    of Restricted Stock Unit Agreement under the Channel Therapeutics Corporation 2023 Equity Incentive Plan (filed as Exhibit
    4.5 to Registrant’s Registration Statement on Form S-8, filed with the SEC on April 15, 2024 and incorporated by reference
    herein).

    10.17
     
    Form of Stock Option Agreement under the Channel Therapeutics Corporation 2023 Equity Incentive Plan (filed as Exhibit 4.6 to Registrant’s Registration Statement on Form S-8, filed with the SEC on April 15, 2024 and incorporated by reference herein).

    10.18+
     
    Side Letter to Amended and Restated Consultant Agreement (Camden Capital) (filed as Exhibit 10.1 to Registrant’s Current Report on Form 8-K, filed with the SEC on May 15, 2024 and incorporated